Akses internasional
Pengobatan kanker di Spanyol
Jaringan rumah sakit akademik dengan studi klinis aktif.
Informasi orientasi, bukan jaminan akses
Fasilitas
Profil referensi publik
Daftar ini tidak menyatakan kemitraan, kualitas, jadwal, harga, atau penerimaan pasien internasional.
NO DATA
Belum ada profil fasilitas yang lolos model referensi publik untuk negara ini.
Registri publik
Uji klinis yang tercatat
Jumlah uji klinis yang tersedia dihitung dari registri publik dan dapat berubah setiap waktu. Angka di halaman ini mengikuti data registri terakhir yang diambil.
NCT06452277Phase 3
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Lung Cancer | biomarker: HER2 | Immunotherapy, Chemotherapy
United States, Argentina, Australia +33279 registry sites
- Registry
- Unknown
- Site
- Not verified
- International access
- Unknown
- Patient match
- Not assessed
Last checked 10 September 2026Source ClinicalTrials.govNCT06452277Not verified
NCT06914128Phase 1 / Phase 2
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
Lung Cancer | Targeted therapy
United States, Australia, Belgium +1063 registry sites
- Registry
- Unknown
- Site
- Not verified
- International access
- Unknown
- Patient match
- Not assessed
Last checked 10 September 2026Source ClinicalTrials.govNCT06914128Not verified
NCT07000253Phase 2
Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma
Stomach Cancer | Immunotherapy, Targeted therapy, Radiotherapy, Chemotherapy
Netherlands, Norway, Spain5 registry sites
- Registry
- Unknown
- Site
- Not verified
- International access
- Unknown
- Patient match
- Not assessed
Last checked 10 September 2026Source ClinicalTrials.govNCT07000253Not verified
NCT07308132Phase 1
A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies
Lymphoma | biomarker: CD20 | Immunotherapy, Chemotherapy
Australia, Belgium, France +219 registry sites
- Registry
- Unknown
- Site
- Not verified
- International access
- Unknown
- Patient match
- Not assessed
Last checked 10 September 2026Source ClinicalTrials.govNCT07308132Not verified
Hal yang perlu dikonfirmasi
- • Persyaratan visa, izin tinggal, dan syarat masuk untuk keperluan medis harus diperiksa pada kanal resmi negara terkait dan kedutaan. TanyaKanker tidak memberikan jaminan penerimaan.
- • Ketersediaan layanan, estimasi tertulis, hal yang termasuk dan tidak termasuk.
- • Rencana tindak lanjut setelah kembali ke Indonesia.
Tanyakan akses di Spanyol
Susun kasus dan pertanyaan tanpa janji penerimaan, harga, atau hasil pengobatan.
Nomor navigator belum dikonfigurasi